A Retrospective Claims Analysis on Rates of Compliance and Discontinuation Among Canadian Multiple Sclerosis Patients Treated with Disease-Modifying Therapies at 6, 12 and 24-Month Periods
Abstract
Authors
P Haddad K Jobin Gervais R Schecter M Yeung P Duquette